Upadacitinib for Refractory Alopecia Areata Unresponsive to Prior Systemic Therapies: A Retrospective Study
Published: 21 November 2024| Version 1 | DOI: 10.17632/zs5fkwwg6d.1
Contributor:
Wang QinDescription
Supplemental table detailing baseline SALT scores, changes in SALT scores, and serum IgE levels for each patient with refractory alopecia areata following treatment with Upadacitinib.
Files
Institutions
Huashan Hospital Fudan University
Categories
Alopecia Areata
Funding
National Natural Science Foundation of China
82373507, 82173442 and 82473552